{"id":38531,"date":"2025-12-27T14:30:56","date_gmt":"2025-12-27T14:30:56","guid":{"rendered":"https:\/\/metachannelcorp.com\/casos-de-exito\/ip-litigation-financing-pharmaceutical\/"},"modified":"2026-07-30T11:46:04","modified_gmt":"2026-07-30T11:46:04","slug":"ip-litigation-financing-pharmaceutical","status":"publish","type":"caso_exito","link":"https:\/\/metachannelcorp.com\/en\/success-stories\/ip-litigation-financing-pharmaceutical\/","title":{"rendered":"Financing of intellectual property litigation in the pharmaceutical industry"},"content":{"rendered":"
\n
\n
Litigation Bridge \u2013 Legal Outcome<\/div>\n
Institutional Connection<\/div>\n
Implementation and Technology: Mode A (Existing Platforms)<\/div>\n
Global Law and Comprehensive Legal Advisory Services<\/div>\n<\/p><\/div>\n

Case Title<\/h2>\n

Intellectual Property Defended: Financing a Patent Dispute<\/p>\n

1. Scenario<\/h2>\n
    \n
  • Client Archetype:<\/strong> Medium-sized pharmaceutical company.<\/li>\n
  • Sector:<\/strong> Pharmaceutical \/ Biotechnology.<\/li>\n
  • Operation Vector:<\/strong> Europe (IP Litigation).<\/li>\n<\/ul>\n

    2. The Strategic Challenge<\/h2>\n

    A pharmaceutical company had developed an innovative process protected by patent, which a larger competitor was clearly infringing. The estimated cost of international intellectual property litigation exceeded 3 million euros, a figure the company could not absorb without putting its operations at risk.<\/p>\n

    3. The META Channel Solution Architecture<\/h2>\n

    Litigation Bridge Capital was activated through its Legal Outcome Funding line specializing in IP & Tech Legal in order to structure the full financing of the litigation. The legal and economic audit of the case was carried out, the recovery potential was assessed and the operation was designed for presentation to international litigation finance funds specializing in intellectual property disputes.<\/p>\n

    4. Ecosystem Orchestration: Layers in Action<\/h2>\n

    Layer 2 (Reference Partners)<\/strong>, coordinated by META Channel, carried out the legal due diligence with pharmaceutical patent experts. Layer 1 (Institutional)<\/strong> connected with international funds specializing in IP litigation and managed the approval process for the operation, while Layer 3 (Operations Platform)<\/strong> coordinated the work of the cross-border legal team throughout the proceedings.<\/p>\n

    5. META Channel Category<\/h2>\n
    \n

    Litigation Bridge \u2013 Legal Outcome.<\/strong> Structures the full financing of high-value litigation through international litigation finance funds, carrying out the legal and economic audit and the assessment of recovery potential.<\/p>\n<\/p><\/div>\n

    6. Strategic Capabilities Deployed<\/h2>\n
    \n
      \n
    • \n \u2611 Institutional Connection<\/strong><\/p>\n
      \n Connection with international funds specializing in IP litigation and management of the approval process for the financing operation.\n <\/div>\n<\/li>\n
    • \n \u2610 Global Regulatory Strategy<\/strong>\n <\/li>\n
    • \n \u2611 Implementation and Technology<\/strong><\/p>\n
        \n
      • \n \u2611 Mode A: Implementation of Existing Platforms<\/strong><\/p>\n
        \n Management of the litigation through platforms coordinating the cross-border legal team throughout the proceedings.\n <\/div>\n<\/li>\n
      • \n \u2610 Mode B: Custom Development (Bespoke Software)\n <\/li>\n<\/ul>\n<\/li>\n
      • \n \u2611 Global Law and Comprehensive Legal Advisory Services<\/strong><\/p>\n
        \n Specialized legal due diligence with pharmaceutical patent experts, legal and economic audit of the case and assessment of recovery potential.\n <\/div>\n<\/li>\n<\/ul><\/div>\n

        7. Key Results<\/h2>\n
          \n
        • Full financing for the litigation secured in 75 days.<\/li>\n
        • The client bore no procedural costs during the 2 years of litigation.<\/li>\n
        • Favorable ruling with 12 million euros in damages.<\/li>\n
        • The company protected its competitive advantage without putting its operations at risk.<\/li>\n<\/ul>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

          Litigation Bridge \u2013 Legal Outcome Institutional Connection Implementation and Technology: Mode A (Existing Platforms) Global Law and Comprehensive Legal Advisory…<\/p>\n","protected":false},"author":1,"featured_media":0,"template":"","meta":{"wds_primary_caso_categoria":0,"footnotes":""},"caso_categoria":[1456,1463,1462,1455,1465,1582],"caso_tag":[1482,1675,1767,1724,1728,1731,1502],"class_list":["post-38531","caso_exito","type-caso_exito","status-publish","caso_categoria-global-law-and-comprehensive-legal-advisory","caso_categoria-implementation-and-technology","caso_categoria-existing-platform-implementation","caso_categoria-institutional-connection","caso_categoria-legal-outcome-en","caso_categoria-litigation-bridge-en","caso_tag-biotechnology","caso_tag-europe","caso_tag-industrial-property","caso_tag-legal-outcome-funding-en","caso_tag-litigation-bridge-capital-en","caso_tag-patent-litigation","caso_tag-pharmaceuticals"],"_links":{"self":[{"href":"https:\/\/metachannelcorp.com\/en\/wp-json\/wp\/v2\/caso_exito\/38531","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/metachannelcorp.com\/en\/wp-json\/wp\/v2\/caso_exito"}],"about":[{"href":"https:\/\/metachannelcorp.com\/en\/wp-json\/wp\/v2\/types\/caso_exito"}],"author":[{"embeddable":true,"href":"https:\/\/metachannelcorp.com\/en\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":1,"href":"https:\/\/metachannelcorp.com\/en\/wp-json\/wp\/v2\/caso_exito\/38531\/revisions"}],"predecessor-version":[{"id":38710,"href":"https:\/\/metachannelcorp.com\/en\/wp-json\/wp\/v2\/caso_exito\/38531\/revisions\/38710"}],"wp:attachment":[{"href":"https:\/\/metachannelcorp.com\/en\/wp-json\/wp\/v2\/media?parent=38531"}],"wp:term":[{"taxonomy":"caso_categoria","embeddable":true,"href":"https:\/\/metachannelcorp.com\/en\/wp-json\/wp\/v2\/caso_categoria?post=38531"},{"taxonomy":"caso_tag","embeddable":true,"href":"https:\/\/metachannelcorp.com\/en\/wp-json\/wp\/v2\/caso_tag?post=38531"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}